Implications of prion diseases for neurosurgery

Neurosurgical Review

Volumn 25, Issue 4, 2002, Pages 195-203

  Blättler, Thomas ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

CJD; Iatrogenic; Neuroinvasion; Prion; Transmission

Indexed keywords

BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; ELECTRODE; ELECTROENCEPHALOGRAM; HUMAN; IATROGENIC DISEASE; INSTRUMENT STERILIZATION; NEUROSURGERY; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; REVIEW; VIRUS PATHOGENESIS; VIRUS RESISTANCE;

DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; HUMANS; IATROGENIC DISEASE; NEUROSURGICAL PROCEDURES; PREVENTIVE MEDICINE; PRION DISEASES; RISK ASSESSMENT;

EID: 0036933457     PISSN: 03445607     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101430100170     Document Type: Review

References (59)

1. Gibbons RA, Hunter GD (1967) Nature of the scrapie agent. Nature 215:1041-1043
2. Latarjet R, Muel B, Haig DA, Clarke MC, Alper T (1970) Inactivation of the scrapie agent by near monochromatic ultraviolet light. Nature 227:1341-1343
3. Stahl N, Borchelt DR, Hsiao K, Prusiner SB (1987) Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51:229-240
4. Basler K, Oesch B, Scott M et al (1986) Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46:417-428
5. Bolton DC, McKinley MP, Prusiner SB (1982) Identification of a protein that purifies with the scrapie prion. Science 218:1309-1311
6. McKinley MP, Bolton DC, Prusiner SB (1983) A protease-resistant protein is a structural component of the scrapie prion. Cell 35:57-62
7. Rick R, Hornemann S, Wider G, Glockshuber R, Wüthrich K (1997) NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett 413:282-288
8. Zhang H, Kaneko K, Nguyen JT et al (1995) Conformational transitions in peptides containing two putative alpha-helices of the prion protein. J Mol Biol 250:514-526
9. Büeler HR, Aguzzi A, Sailer A et al (1993) Mice devoid of PrP are resistant to scrapie. Cell 73:1339-1347
10. Kocisko DA, Come JH, Priola SA et al (1994) Cell-free formation of protease-resistant prion protein [see comments]. Nature 370:471-474
11. Hill AF, Antoniou M, Collinge J (1999) Protease-resistant prion protein produced in vitro lacks detectable infectivity. J Gen Virol 80:11-14
12. Pattison IH (1965) Scrapie in the Welsh mountain breed of sheep and its experimental transmission to goats. Vet Rec 77:1388-1390
13. Scott M, Foster D, Mirenda C et al (1989) Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59:847-857
14. Hill AF, Joiner S, Linehan J, Desbruslais M, Lantos PL, Collinge J (2000) Species-barrier-independent prion replication in apparently resistant species. Proc Natl Acad Sci USA 97:10248-10253
15. Dickinson AG, Meikle VM (1971) Host-genotype and agent effects in scrapie incubation: change in allelic interaction with different strains of agent. Mol Gen Genet 112:73-79
16. Fraser H, Dickinson AG (1973) Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation. J Comp Pathol 83:29-40
17. Gibbs CJ Jr, Gajdusek DC (1971) Transmission and characterization of the agents of spongiform virus encephalopathies: kuru, Creutzfeldt-Jakob disease, scrapie and mink encephalopathy. Res Publ Assoc Res Nerv Ment Dis 49:383-410
18. Hecker R, Taraboulos A, Scott M et al (1992) Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters. Genes Dev 6:1213-1228
19. Eklund CM, Kennedy RC, Hadlow WJ (1967) Pathogenesis of scrapie virus infection in the mouse. J Infect Dis 117:15-22
20. Clarke MC, Kimberlin RH (1984) Pathogenesis of mouse scrapie: distribution of agent in the pulp and stroma of infected spleens. Vet Microbiol 9:215-225
21. Fraser H, Farquhar CF, McConnell I, Davies D (1989) The scrapie disease process is unaffected by ionising radiation. Prog Clin Biol Res 317:653-658
22. Kitamoto T, Muramoto T, Mohri S, Doh ura K, Tateishi J (1991) Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt-Jakob disease. J Virol 65:6292-6295
23. O'Rourke KI, Huff TP, Leathers CW, Robinson MM, Gorham JR (1994) SCID mouse spleen does not support scrapie agent replication. J Gen Virol 75:1511-1514
24. Lasmezas CI, Cesbron JY, Deslys JP et al (1996) Immune system-dependent and -independent replication of the scrapie agent. J Virol 70:1292-1295
25. Fraser H, Brown KL, Stewart K, McConnell I, McBride P, Williams A (1996) Replication of scrapie in spleens of scid mice follows reconstitution with wild-type mouse bone marrow. J Gen Virol 77:1935-1940
26. Kimberlin RH, Walker CA (1980) Pathogenesis of mouse scrapie: evidence for neural spread of infection to the CNS. J Gen Virol 51:183-187
27. Kimberlin RH, Walker CA (1986) Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly. J Gen Virol 67:255-263
28. Kimberlin RH, Hall SM, Walker CA (1983) Pathogenesis of mouse scrapie. Evidence for direct neural spread of infection to the CNS after injection of sciatic nerve. J Neurol Sci 61:315-325
29. Brandner S, Isenmann S, Raeber A et al (1996) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379:339-343
30. Blättler T, Brandner S, Raeber AJ et al (1997) PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature 389:69-73
31. Glatzel M, Aguzzi A (2000) PrP(C) expression in the peripheral nervous system is a determinant of prion neuroinvasion. J Gen Virol 81:2813-2821
32. Klein MA, Frigg R, Flechsig E et al (1997) A crucial role for B cells in neuroinvasive scrapie. Nature 390:687-690
33. Klein MA, Frigg R, Raeber AJ et al (1998) PrP expression in B lymphocytes is not required for prion neuroinvasion. Nat Med 4:1429-1433
34. Fischer MB, Roeckl C, Parizek P, Schwarz HP, Aguzzi A (2000) Binding of disease-associated prion protein to plasminogen. Nature 408:479-483
35. Finkenstaedt M, Szudra A, Zerr I et al (1996) MR imaging of Creutzfeldt-Jakob disease. Radiology 199:793-798
36. Will R, Ironside JW, Zeidler M et al (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921-925
37. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF (1996) Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383:685-690
38. Bruce ME, Will RG, Ironside JW et al (1997) Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent [see comments]. Nature 389:498-501
39. Will R, Cousens S, Farrington C, Smith P, Knight R, Ironside J (1999) Deaths from variant Creutzfeldt-Jakob disease. Lancet 353:9157-9158
40. Ironside JW, Hilton DA, Ghani A et al (2000) Retrospective study of prion-protein accumulation in tonsil and appendix tissues [letter]. Lancet 355:1693-1694
41. Will RG, Matthews WB (1982) Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 45:235-238
42. Bernoulli C, Siegfried J, Baumgartner G et al (1977) Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery [letter]. Lancet 1:478-479
43. Lang CJ, Heckmann JG, Neundorfer B (1998) Creutzfeldt-Jakob disease via dural and corneal transplants. J Neurol Sci 160:128-139
44. Brown P PM, Brandel JP, Sato T, McShane L, Zerr I, Fletcher A, Will RG, Pocchiari M, Cashman NR, d'Aignaux JH, Cervenakova L, Fradkin J, Schonberger LB, Collins SJ (2000) Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 55:1075-1081
45. Brown P, Preece MA, Will RG (1992) "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet 340:24-27
46. d'Aignaux JH, Maccario J, Billette de Villemeur T, Brandel JP, Deslys JP, Hauw JJ, Chaussain JL, Agid Y, Dormont D, Alpérovitch A (1999) Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France. Neurology 53:1197
47. Alperovitch A, Zerr I, Pocchiari M et al (1999) Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease [letter]. Lancet 353:1673-1674
48. Antoine JC, Michel D, Bertholon P et al (1997) Creutzfeldt-Jakob disease after extracranial dura mater embolization for a nasopharyngeal angiofibroma. Neurology 48:1451-1453
49. Defebvre L, Destee A, Caron J, Ruchoux MM, Wurtz A, Remy J (1997) Creutzfeldt-Jakob disease after an embolization of intercostal arteries with cadaveric dura mater suggesting a systemic transmission of the prion agent. Neurology 48:1470-1471
50. Houston F, Foster JD, Chong A, Hunter N, Bostock CJ (2000) Transmission of BSE by blood transfusion in sheep. Lancet 356:999-1000
51. Brown P, Cervenakova L, McShane LM, Barber P, Rubenstein R, Drohan WN (1999) Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion 39:1169-1178
52. Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL (1999) Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 353:693-697
53. Zerr I BJ, Masullo C, Wientjens D, de Silva R, Zeidler M, Granieri E, Sampaolo S, van Duijn C, Delasnerie-Laupretre N, Will R, Poser S (2000) European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors. J Clin Epidemiol 53:747-754
54. Berger JR, David NJ (1993) Creutzfeldt-Jakob disease in a physician: a review of the disorder in health care workers. Neurology 43:205-206
55. Weber T, Tumani H, Holdorff B et al (1993) Transmission of Creutzfeldt-Jakob disease by handling of dura mater [letter]. Lancet 341:123-124
56. Berger JR, David NJ (1993) Creutzfeldt-Jakob disease in a physician: a review of the disorder in health care workers. Neurology 43:205-206
57. Mitrova EBG (2000) Creutzfeldt-Jakob disease in health professionals in Slovakia. Eur J Epidemiol 16:353-355
58. Taylor DM (1993) Inactivation of SE agents. Br Med Bull 49:810-821
59. Aguzzi A, Collinge J (1997) Post-exposure prophylaxis after accidental prion inoculation. Lancet 350:1519-1520